Alloy
Waltham, US · Founded 2017 · 152 employees on LinkedIn · 4 known investors
Alloy provides drug discovery services and platform technologies across genetic medicines, TCR mimics, and cell therapies, supporting pharmaceutical partners in developing novel treatments.
Founders & leadership
Alloy was founded in 2017 by Tillman Gerngross.
TG
Tillman GerngrossFounder, CEO, Chairman
Investors · 4
Competitors · 2
by search overlap
IQVIA49 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Bioworld47 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Alloy for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Alloy do?
- Alloy provides drug discovery services and platform technologies across genetic medicines, TCR mimics, and cell therapies, supporting pharmaceutical partners in developing novel treatments.
- Who founded Alloy?
- Alloy was founded by Tillman Gerngross in 2017.
- Who are Alloy's investors?
- Alloy's investors include 82VS, 8VC, Calm Ventures, Germin8 Ventures.
- Where is Alloy headquartered?
- Alloy is headquartered in Waltham, US.